Insulin detemir is associated with more predictable glycemic control and lower risk of hypoglycemia compared to NPH insulin in subjects with type 1 diabetes

被引：0

|

作者：

Vague, P

Selam, JL

Skeie, S

De Leeuw, I

Willem, J

Elte, F

Haahr, H

Kristensen, A

Draeger, E

机构：

来源：

DIABETES | 2002年 / 51卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

473

引用

收藏

页码：A116 / A117

页数：2

相关论文

共 50 条

[41] Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia
Erik Johansen, Odd
Johan Vanberg, Pal
Kvarv Kilhovd, Bente
Palmstrom Jorgensen, Anders
[J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 : 121 - 128
[42] Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes
Tentolouris, Anastasios
Eleftheriadou, Ioanna
Tentolouris, Nikolaos
[J]. ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (03)
[43] Hypoglycemia and glycemic control in type 1 diabetes: a meta-analysis of five randomized controlled trials comparing NPH insulin with insulin glargine
Mullins, Peter
Jarvinen, Hannele Yki
Sharplin, Peter A.
Riddle, Matthew
[J]. DIABETES, 2007, 56 : A575 - A576
[44] Dose-response relationship and within-subject variability of insulin detemir and NPH insulin in subjects with type 1 diabetes
Wutte, A
Plank, J
Sinner, F
Druml, T
Sommer, R
Zdravkovic, M
Ronn, BB
Draeger, E
Pieber, TR
[J]. DIABETES, 2004, 53 : A152 - A152
[45] Beneficial effects of insulin glargine compared to NPH in subjects with type 1 diabetes.
Hershon, K
Blevins, T
Donley, D
Littlejohn, C
[J]. DIABETOLOGIA, 2001, 44 : A15 - A15
[46] Lower pasting blood glucose (FBG) and less symptomatic hypoglycemia with QD insulin glargine (Lantus®) compared to BID NPH in subjects with type 1 diabetes
Hershon, K
Blevins, T
Donley, D
Littlejohn, C
[J]. DIABETES, 2001, 50 : A116 - A117
[47] Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir; long-term experience in 105 children and adolescents with type 1 diabetes
Braun, Doris
Konrad, Daniel
Lang-Muritano, Mariarosaria
Schoenle, Eugen
[J]. PEDIATRIC DIABETES, 2008, 9 (04) : 382 - 387
[48] Insulin detemir reduces hypoglycemic risk at comparable HbA1c values compared to NPH in patients with type 1 diabetes
Heller, S
Kim, H
[J]. DIABETES, 2005, 54 : A120 - A120
[49] Higher insulin detemir doses are required for the similar glycemic control: comparison of insulin detemir and glargine in children with type 1 diabetes mellitus
Abali, Saygin
Turan, Serap
Atay, Zeynep
Guran, Tulay
Haliloglu, Belma
Bereket, Abdullah
[J]. PEDIATRIC DIABETES, 2015, 16 (05) : 361 - 366
[50] Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes A systematic review and meta-analysis
Szypowska, Agnieszka
Golicki, Dominik
Groele, Lidia
Pankowska, Ewa
[J]. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2011, 121 (7-8): : 237 - 246

← 1 2 3 4 5 →